ETERNA THERAPEUTICS INC (ERNA) Stock Price, Quote, News and Overview
NASDAQ:ERNA - Nasdaq - US1140822099 - Common Stock - Currency: USD
ERNA Quote, Performance and Key Statistics
0.3389
-0.01 (-3.61%)
The current stock price of ERNA is 0.3389 USD. In the past month the price decreased by -46.64%. In the past year, price decreased by -78.28%.
ERNA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.85 | 354.98B | ||
| AMGN | AMGEN INC | 15.03 | 159.99B | ||
| GILD | GILEAD SCIENCES INC | 23.87 | 137.10B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1656.31 | 123.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.25 | 76.09B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.34B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.37B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.26B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.06B | ||
| NTRA | NATERA INC | N/A | 22.20B | ||
| BIIB | BIOGEN INC | 8.32 | 19.98B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.01B |
Related stock screener links
About ERNA
Company Profile
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 8 full-time employees. The firm has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.
Company Info
ETERNA THERAPEUTICS INC
1035 Cambridge Street, Suite 18A
Cambridge MASSACHUSETTS US
Employees: 8
Company Website: https://eternatx.com/
Investor Relations: https://investor.eternatx.com/
Phone: 12125821199
ETERNA THERAPEUTICS INC / ERNA FAQ
What is the stock price of ETERNA THERAPEUTICS INC today?
The current stock price of ERNA is 0.3389 USD. The price decreased by -3.61% in the last trading session.
What is the ticker symbol for ETERNA THERAPEUTICS INC stock?
The exchange symbol of ETERNA THERAPEUTICS INC is ERNA and it is listed on the Nasdaq exchange.
On which exchange is ERNA stock listed?
ERNA stock is listed on the Nasdaq exchange.
What is ETERNA THERAPEUTICS INC worth?
ETERNA THERAPEUTICS INC (ERNA) has a market capitalization of 17.41M USD. This makes ERNA a Nano Cap stock.
How many employees does ETERNA THERAPEUTICS INC have?
ETERNA THERAPEUTICS INC (ERNA) currently has 8 employees.
What are the support and resistance levels for ETERNA THERAPEUTICS INC (ERNA) stock?
ETERNA THERAPEUTICS INC (ERNA) has a support level at 0.26 and a resistance level at 0.36. Check the full technical report for a detailed analysis of ERNA support and resistance levels.
Should I buy ETERNA THERAPEUTICS INC (ERNA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ERNA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ERNA, evaluating the profitability, health, valuation and growth aspects
- ETERNA THERAPEUTICS INC (ERNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ETERNA THERAPEUTICS INC (ERNA) Sales and EPS estimates to see what analysts future expectations are.
- ETERNA THERAPEUTICS INC (ERNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ETERNA THERAPEUTICS INC (ERNA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ETERNA THERAPEUTICS INC (ERNA) Stock Chart to make your own analysis
- ETERNA THERAPEUTICS INC (ERNA) Latest news and press-releases to stay up to date.
Does ETERNA THERAPEUTICS INC (ERNA) stock pay dividends?
ERNA does not pay a dividend.
When does ETERNA THERAPEUTICS INC (ERNA) report earnings?
ETERNA THERAPEUTICS INC (ERNA) will report earnings on 2025-03-12.
What is the Price/Earnings (PE) ratio of ETERNA THERAPEUTICS INC (ERNA)?
ETERNA THERAPEUTICS INC (ERNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.31).
What is the Short Interest ratio of ETERNA THERAPEUTICS INC (ERNA) stock?
The outstanding short interest for ETERNA THERAPEUTICS INC (ERNA) is 1.09% of its float. Check the ownership tab for more information on the ERNA short interest.
ERNA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ERNA. When comparing the yearly performance of all stocks, ERNA is a bad performer in the overall market: 97.23% of all stocks are doing better.
ERNA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ERNA. ERNA has a bad profitability rating. Also its financial health evaluation is rather negative.
ERNA Financial Highlights
Over the last trailing twelve months ERNA reported a non-GAAP Earnings per Share(EPS) of -8.31. The EPS decreased by -98.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -582.39% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ERNA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to ERNA. The Buy consensus is the average rating of analysts ratings from 6 analysts.